These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17660029)

  • 1. Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes.
    Eloot S; Torremans A; De Smet R; Marescau B; De Deyn PP; Verdonck P; Vanholder R
    Am J Kidney Dis; 2007 Aug; 50(2):279-88. PubMed ID: 17660029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds.
    Eloot S; Torremans A; De Smet R; Marescau B; De Wachter D; De Deyn PP; Lameire N; Verdonck P; Vanholder R
    Kidney Int; 2005 Apr; 67(4):1566-75. PubMed ID: 15780113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis.
    Eloot S; van Biesen W; Dhondt A; de Smet R; Marescau B; De Deyn PP; Verdonck P; Vanholder R
    Nephrol Dial Transplant; 2009 Jul; 24(7):2225-32. PubMed ID: 19225018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of uremic toxicity.
    Vanholder RC; Glorieux GL
    Hemodial Int; 2003 Apr; 7(2):156-61. PubMed ID: 19379356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
    Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
    Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of water-soluble and protein-bound solutes with reversed mid-dilution versus post-dilution haemodiafiltration.
    Eloot S; Dhondt A; Van Landschoot M; Waterloos MA; Vanholder R
    Nephrol Dial Transplant; 2012 Aug; 27(8):3278-83. PubMed ID: 22492823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion kinetics of urea, creatinine and uric acid in blood during hemodialysis. Clinical implications.
    Descombes E; Perriard F; Fellay G
    Clin Nephrol; 1993 Nov; 40(5):286-95. PubMed ID: 8281718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinetics of potassium transfer during hemodialysis].
    Bulliard C; Guignard JP; Ruiz J; Moret H; Fellay G
    Nephrologie; 2001; 22(1):15-9. PubMed ID: 11280036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte transketolase activity and guanidino compounds in hemodialysis patients.
    Pietrzak I; Baczyk K
    Kidney Int Suppl; 2001 Feb; 78():S97-101. PubMed ID: 11168992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound.
    Giannattasio P; Minutolo R; Bellizzi V; Di Iorio BR; Scigliano R; Zamboli P; Venditti G; Manganelli R; De Simone W; Aucella F; Stallone C; Spiezia S; Conte G; De Nicola L
    Am J Kidney Dis; 2006 Jun; 47(6):1045-54. PubMed ID: 16731300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
    Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
    Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney.
    Levillain O; Marescau B; Possemiers I; De Deyn P
    Pflugers Arch; 2002 May; 444(1-2):143-52. PubMed ID: 11976926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of transcellular transport kinetics of urea and creatinine for haemodialysis (author's transl)].
    Zimmermann E; Pölz E
    Wien Klin Wochenschr; 1981 Sep; 93(16):519-21. PubMed ID: 7303697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.